Show simple item record

dc.contributor.authorSteinke, Elaine E.
dc.contributor.authorHill, Twyla J.
dc.contributor.authorMosack, Victoria
dc.date.accessioned2016-02-29T15:09:05Z
dc.date.available2016-02-29T15:09:05Z
dc.date.issued2016-02
dc.identifier.citationSteinke, E. E., Hill, T. J. and Mosack, V. (2016), Medication use and predictors of sexual activity in men and women with CVD. American Assoc Nurse Prac, 28: 91–97. doi: 10.1002/2327-6924.12253en_US
dc.identifier.issn2327-6886
dc.identifier.otherWOS:000369159500007
dc.identifier.urihttp://dx.doi.org/10.1002/2327-6924.12253
dc.identifier.urihttp://hdl.handle.net/10057/11948
dc.descriptionClick on the DOI link to access the article (may not be free).en_US
dc.description.abstractPurposeTo examine the influence of cardiac and noncardiac medications on sexual activity by drug classification and generation of the drug, among men and women with cardiovascular disease. Data sourcesThis study was a subanalysis (n = 224) of survey data from a cross-sectional sample of 336 cardiac patients. Self-reported medications were categorized by generic drug name, classification, and subclass and/or generation of the drug. Sexual activity was the presence or absence of current sexual activity in the last 2 months. ConclusionsPatients taking generation one beta blockers, particularly men; diuretics as a class; and loop diuretics, were significantly less likely to be sexually active, with diuretics negatively influencing sexual activity in women, but not men. Certain antidepressant medications positively influenced sexual function, particularly for women. Nearly 20% of the variances in sexual activity were explained by younger age, fewer number of medications, higher education, and having a sexual partner. Implications for practiceA new finding meriting further study was that loop diuretics negatively impacted sexual activity, particularly for women; and further studies of women overall are clearly needed. Advance practice nurses play an important role in evaluating medications, proactively choosing drugs within a class or subclass less likely to cause sexual problems, and in promoting sexual quality of life of cardiac patients.en_US
dc.language.isoen_USen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.relation.ispartofseriesJournal of the American Association of Nurse Practitioners;v.28:no.2
dc.subjectSexual intimacyen_US
dc.subjectSexual healthen_US
dc.subjectCardiovascular diseaseen_US
dc.subjectMedicationsen_US
dc.titleMedication use and predictors of sexual activity in men and women with CVDen_US
dc.typeArticleen_US
dc.rights.holder©2015 American Association of Nurse Practitionersen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record